The National Quality Forum’s Measure Applications Partnership recently released guidelines on measures for the new Merit-Based Incentive Payment System and on cross-cutting issues for all federal healthcare programs.
The National Quality Forum (NQF)’s Measure Applications Partnership (MAP) recently released guidelines on measures for the new Merit-Based Incentive Payment System (MIPS) and on cross-cutting issues for all federal healthcare programs.
The recommendations, presented by MAP, for measures in these programs, reflect how well the measures address the identified program goals, as well as NQF’s prior work in identifying families of measures. Some of the dominating issues for clinician programs identified included: the new MIPS aligning all clinician measures into a single program; further alignment of clinician measures warranted with alternative payment model and hospital/facility measures; increased public reporting of clinician measures on Physician Compare; and measuring gaps in both MIPS and Medicare Shared Savings Program.
For the purpose of the review, MAP considered 60 performance measures for use in MIPS. MIPS is a program legislated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) in CMS. MIPS combines the Physician Quality Reporting System, the Value Modifier, and the Medicare Electronic Health Record incentive program into a single program. This single program is responsible for adjusting eligible providers’ Medicare payments based on performance.
“As the US healthcare system increasingly shifts to a performance-based payment system, MAP’s role as an impartial advisor bringing stakeholders together from across the healthcare spectrum is more important than ever,” said Helen Burstin, NQF’s chief scientific officer. “The recommendations MAP made for MIPS, MSSP, and other federal healthcare programs are advancing measurement to help make better healthcare a reality for all Americans.”
Exploring in detail, the following recommendations were proposed on cross-cutting issues to HHS:
This report highlights major changes in the types of measures submitted for consideration for use and notes that this year, for the first time, more outcome measures were submitted for consideration than process measures.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More